Oral treatment of onychomycosis pays off in the long run

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1286, 2001-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab pays off long term

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Oral Terbinafine (Lamisil) Compared with Oral Fluconazole (Diflucan) in the Treatment of Patients with Toenail Onychomycosis

By Salo H. Pekurinen M.

PharmacoEconomics, Vol. 20, Iss. 5, 2002-01 ,pp. : 319-324

Adis International

Access to resources Recommend Favorite

Holding off dialysis pays off

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Posaconazole prophylaxis pays off

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Posaconazole prophylaxis pays off

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 553, 2008-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite